These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33296022)

  • 1. Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Härdtner C; Kornemann J; Krebs K; Ehlert CA; Jander A; Zou J; Starz C; Rauterberg S; Sharipova D; Dufner B; Hoppe N; Dederichs TS; Willecke F; Stachon P; Heidt T; Wolf D; von Zur Mühlen C; Madl J; Kohl P; Kaeser R; Boettler T; Pieterman EJ; Princen HMG; Ho-Tin-Noé B; Swirski FK; Robbins CS; Bode C; Zirlik A; Hilgendorf I
    Basic Res Cardiol; 2020 Dec; 115(6):78. PubMed ID: 33296022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
    Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
    Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
    Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
    Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
    Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
    Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.
    Xu L; Wang YR; Li PC; Feng B
    Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.
    Potteaux S; Gautier EL; Hutchison SB; van Rooijen N; Rader DJ; Thomas MJ; Sorci-Thomas MG; Randolph GJ
    J Clin Invest; 2011 May; 121(5):2025-36. PubMed ID: 21505265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
    Wang Y; Parlevliet ET; Geerling JJ; van der Tuin SJ; Zhang H; Bieghs V; Jawad AH; Shiri-Sverdlov R; Bot I; de Jager SC; Havekes LM; Romijn JA; Willems van Dijk K; Rensen PC
    Br J Pharmacol; 2014 Feb; 171(3):723-34. PubMed ID: 24490861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.
    Williams JW; Martel C; Potteaux S; Esaulova E; Ingersoll MA; Elvington A; Saunders BT; Huang LH; Habenicht AJ; Zinselmeyer BH; Randolph GJ
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1702-1710. PubMed ID: 29903736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholesterol re-supplementation and atorvastatin on plaque composition in the thoracic aorta of New Zealand white rabbits.
    Bonaterra GA; Bender K; Wilhelm B; Schwarzbach H; Metz S; Kelber O; Weiser D; Metz J; Kinscherf R
    BMC Cardiovasc Disord; 2020 Sep; 20(1):420. PubMed ID: 32942987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenomenon of atherosclerosis reversal and regression: Lessons from animal models.
    Chistiakov DA; Myasoedova VA; Revin VV; Orekhov AN; Bobryshev YV
    Exp Mol Pathol; 2017 Feb; 102(1):138-145. PubMed ID: 28108216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation.
    Sun H; Jiang J; Gong L; Li X; Yang Y; Luo Y; Guo Z; Lu R; Li H; Li J; Zhao J; Yang N; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109352. PubMed ID: 31586905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
    Auvinen HE; Wang Y; Princen H; Romijn JA; Havekes LM; Smit JW; Meijer OC; Biermasz NR; Rensen PC; Pereira AM
    PLoS One; 2013; 8(5):e63882. PubMed ID: 23717502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins Disrupt Macrophage Rac1 Regulation Leading to Increased Atherosclerotic Plaque Calcification.
    Healy A; Berus JM; Christensen JL; Lee C; Mantsounga C; Dong W; Watts JP; Assali M; Ceneri N; Nilson R; Neverson J; Wu WC; Choudhary G; Morrison AR
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):714-732. PubMed ID: 31996022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
    Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.